Results 161 to 170 of about 35,486 (225)

Public health role for fractional dosage of yellow fever vaccine. [PDF]

Lancet, 2021
Staples JE, Alvarez AR.
europepmc   +1 more source

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial. [PDF]

Lancet Infect Dis, 2023
Kimathi D, Juan-Giner A, Orindi B, Grantz KH, Bob NS, Cheruiyot S, Hamaluba M, Kamau N, Fall G, Dia M, Mosobo M, Moki F, Kiogora K, Chirro O, Thiong'o A, Mwendwa J, Guantai A, Karanja HK, Gitonga J, Mugo D, Ramko K, Faye O, Sanders EJ, Grais RF, Bejon P, Warimwe GM.   +25 more
europepmc   +1 more source

A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers. [PDF]

Vaccines (Basel)
Fukushima S, Lim CK, Hamada A.
europepmc   +1 more source

Safety and Immunogenicity of the Attenuated Yellow Fever Vaccine in Several Neotropical Primate Species. [PDF]

Vaccines (Basel)
Paula NF, Vieira AD, Santos DOD, Souza LDR, Coelho CM, Tinoco HP, Lima PCS, Motta ROC, Pereira VDS, Carvalho MPN, Fernandes CB, Azevedo AS, Arruda MS, Costa TA, Drumond BP, Leme FOP, Freire MDS, Paixão TAD, Oliveira AR, Santos RL.   +19 more
europepmc   +1 more source

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study. [PDF]

Trials, 2022
Mackenzie GA, Osei I, Salaudeen R, Secka O, D'Alessandro U, Clarke E, Schmidt-Chanasit J, Licciardi PV, Nguyen C, Greenwood B, Mulholland K.   +10 more
europepmc   +1 more source

ePoster

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to standard dose in children 9-23 months old in Uganda, 2019-2022 - final report. [PDF]

Vaccine
Lee SE, Najjengo M, Shaum A, Sekiziyivu AB, Carlock G, Casey RM, Lubega I, Tumwine C, Twinomuhwezi-Oyet E, Nakato WN, Sciarratta CN, Hyde TB, Chu SY, Doshi RH, Kambugu A, Gidudu JF.   +15 more
europepmc   +1 more source

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial. [PDF]

PLoS Negl Trop Dis, 2023
Sandberg JT, Löfling M, Varnaitė R, Emgård J, Al-Tawil N, Lindquist L, Gredmark-Russ S, Klingström J, Loré K, Blom K, Ljunggren HG.   +10 more
europepmc   +1 more source

Reaching Forest Workers with Yellow Fever Vaccine Through Engagement of the Private Sector in Central African Republic. [PDF]

Vaccines (Basel)
Noufack G, Bissengue P, Zobanga JK, Malingao JSC, Keita M, Razaiarimanga MC, Raguenaud ME.   +6 more
europepmc   +1 more source

Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals. [PDF]

An Bras Dermatol, 2021
Almeida LR, Criado RF, Criado PR, Ensina LF, Abdalla BMZ, Quaresma JAS.   +5 more
europepmc   +1 more source